Effects of almond consumption on the reduction of LDL-cholesterol: A discussion of potential mechanisms and future research directions

Nutrition Reviews

Volumn 69, Issue 4, 2011, Pages 171-185

  Berryman, Claire E ^a   Preston, Amy Griel ^a   Karmally, Wahida ^b   Deckelbaum, Richard J ^c   Kris Etherton, Penny M ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

Almonds; Antioxidants; Dietary fiber; Low density lipoprotein cholesterol; Phytosterols; Unsaturated fatty acids

Indexed keywords

ALPHA TOCOPHEROL; ARGININE; BILE ACID; CALCIUM; COPPER; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MAGNESIUM; MANGANESE; PHYTOSTEROL; POTASSIUM; SATURATED FATTY ACID; UNSATURATED FATTY ACID; VEGETABLE PROTEIN;

ALMOND; BILE ACID METABOLISM; CARDIOVASCULAR DISEASE; CHOLESTEROL SYNTHESIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET; EDITORIAL; FIBER; FOOD INTAKE; HEART PROTECTION; HYPERCHOLESTEROLEMIA;

ANTICHOLESTEREMIC AGENTS; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; HUMANS; PRUNUS;

PRUNUS DULCIS;

EID: 79953274491     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2011.00383.x     Document Type: Editorial

References (130)

1. World Health Organization. The Global Burden of Disease: 2004 Update. Geneva: World Health Organization; 2008. Accessed June 2010.
2. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, etal. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011;123(4):e18-e209.
3. National Cholesterol Education Program. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
4. Grundy SM, Cleeman JI, Bairey Merz CN, etal. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. J Am Coll Cardiol. 2004;44:720-732.
5. Krauss RM, Eckel RH, Howard B, etal. AHA dietary guidelines revision 2000: a statement for healthcare professionals from the nutrition committee of the American Heart Association. Circulation. 2000;102:2284-2299.
6. Fung TT, Willett WC, Stampfer MJ, Manson JE, Hu FB. Dietary patterns and the risk of coronary heart disease in women. Arch Intern Med. 2001;161:1857-1862.
7. Hu FB, Rimm EB, Stampfer MJ, Ascherio A, Spiegelman D, Willett WC. Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr. 2000;72:912-921.
8. Ding EL, Mozaffarian D. Optimal dietary habits for the prevention of stroke. Semin Neurol. 2006;26:11-23.
9. Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009;169:659-669.
10. Jenkins DJA, Kendall CWC, Faulkner D, etal. A dietary portfolio approach to cholesterol reduction: combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia. Metabolism. 2002;51:1596-1604.
11. Hu F, Stampfer M. Nut consumption and risk of coronary heart disease: a review of epidemiologic evidence. Curr Atheroscler Rep. 1999;1:204-209.
12. Albert CM, Gaziano JM, Willett WC, Manson JE. Nut consumption and decreased risk of sudden cardiac death in the Physicians' Health Study. Arch Intern Med. 2002;162:1382-1387.
13. Fraser GE, Sabate J, Beeson WL, Strahan TM. A possible protective effect of nut consumption on risk of coronary heart disease: the Adventist Health Study. Arch Intern Med. 1992;152:1416-1424.
14. Ellsworth JL, Kushi LH, Folsom AR. Frequent nut intake and risk of death from coronary heart disease and all causes in postmenopausal women: the Iowa Women's Health Study. Nutr Metab Cardiovasc Dis. 2001;11:372-377.
15. Hu FB, Stampfer MJ, Manson JE, etal. Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study. BMJ. 1998;317:1341-1345.
16. Jiang R, Manson JE, Stampfer MJ, Liu S, Willett WC, Hu FB. Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA. 2002;288:2554-2560.
17. Fraser GE, Shavlik DJ. Risk factors for all-cause and coronary heart disease mortality in the oldest-old: the Adventist Health Study. Arch Intern Med. 1997;157:2249-2258.
18. Sabate J, Oda K, Ros E. Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Arch Intern Med. 2010;170:821-827.
19. Kris-Etherton PM, Yu-Poth S, Sabate J, Ratcliffe HE, Zhao G, Etherton TD. Nuts and their bioactive constituents: effects on serum lipids and other factors that affect disease risk. Am J Clin Nutr. 1999;70(Suppl):S504-S511.
20. Griel AE, Kris-Etherton PM. Tree nuts and the lipid profile: a review of clinical studies. Br J Nutr. 2006;96(Suppl 2):S68-S78.
21. Kris-Etherton PM, Hu FB, Ros E, Sabate J. The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms. J Nutr. 2008;138(Suppl):S1746-S1751.
22. Abbey M, Noakes M, Belling GB, Nestel PJ. Partial replacement of saturated fatty acids with almonds or walnuts lowers total plasma cholesterol and low-density-lipoprotein cholesterol. Am J Clin Nutr. 1994;59:995-999.
23. Spiller GA, Jenkins DAJ, Bosello O, Gates JE, Cragen LN, Bruce B. Nuts and plasma lipids: an almond-based diet lowers LDL-C while preserving HDL-C. J Am Coll Nutr. 1998;17:285-290.
24. Hyson DA, Schneeman BO, Davis PA. Almonds and almond oil have similar effects on plasma lipids and LDL oxidation in healthy men and women. J Nutr. 2002;132:703-707.
25. Jenkins DJA, Kendall CWC, Marchie A, etal. Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial. Circulation. 2002;106:1327-1332.
26. Lovejoy JC, Most MM, Lefevre M, Greenway FL, Rood JC. Effect of diets enriched in almonds on insulin action and serum lipids in adults with normal glucose tolerance or type 2 diabetes. Am J Clin Nutr. 2002;76:1000-1006.
27. Wien MA, Sabaté JM, Iklé DN, Cole SE, Kandeel FR. Almonds versus complex carbohydrates in a weight reduction program. Int J Obes Relat Metab Disord. 2003;27:1365-1372.
28. Sabate J, Haddad E, Tanzman JS, Jambazian P, Rajaram S. Serum lipid response to the graduated enrichment of a Step I diet with almonds: a randomized feeding trial. Am J Clin Nutr. 2003;77:1379-1384.
29. Spiller GA, Miller A, Olivera K, etal. Effects of plant-based diets high in raw or roasted almonds, or roasted almond butter on serum lipoproteins in humans. J Am Coll Nutr. 2003;22:195-200.
30. Jenkins DJA, Kendall CWC, Marchie A, etal. The effect of combining plant sterols, soy protein, viscous fibers, and almonds in treating hypercholesterolemia. Metabolism. 2003;52:1478-1483.
31. Tamizifar B, Rismankarzadeh M, Vosoughi A-A, etal. A low-dose almond-based diet decreases LDL-C while preserving HDL-C. Arch Iranian Med. 2005;8(1):45-51.
32. Jia X, Li N, Zhang W, etal. A pilot study on the effects of almond consumption on DNA damage and oxidative stress in smokers. Nutr Cancer. 2006;54:179-183.
33. Li S-C, Liu Y-H, Liu J-F, Chang W-H, Chen C-M, Chen CYO. Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus. Metabolism. 2010:doi:10.1016/j.metabol.2010.04.009.
34. Phung OJ, Makanji SS, White CM, Coleman CI. Almonds have a neutral effect on serum lipid profiles: a meta-analysis of randomized trials. J Am Diet Assoc. 2009;109:865-873.
35. U.S. Department of Agriculture, Agricultural Research Service. USDA National Nutrient Database for Standard Reference, Release 22. 2009. Nutrient Data Laboratory Home Page, Accessed February 2010.
36. Sathe SK, Seeram NP, Kshirsagar HH, Heber D, Lapsley KA. Fatty acid composition of California-grown almonds. J Food Sci. 2008;73:C607-C614.
37. Kris-Etherton P, Krummel D, Russell M, etal. The effect of diet on plasma lipids, lipoproteins, and coronary heart disease. J Am Diet Assoc. 1988;88:1373-1400.
38. Mustad VA, Etherton TD, Cooper AD, etal. Reducing saturated fat intake is associated with increased levels of LDL receptors on mononuclear cells in healthy men and women. J Lipid Res. 1997;38:459-468.
39. Berglund L, Lefevre M, Ginsberg HN, etal. Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. Am J Clin Nutr. 2007;86:1611-1620.
40. Egert S, Kratz M, Kannenberg F, Fobker M, Wahrburg U. Effects of high-fat and low-fat diets rich in monounsaturated fatty acids on serum lipids, LDL size and indices of lipid peroxidation in healthy non-obese men and women when consumed under controlled conditions. Eur J Nutr. 2010:doi:10.1007/s00394-010-0116-9.
41. Mensink RP, Zock PL, Kester ADM, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;77(5):1146-1155.
42. Hegsted DM, Ausman LM, Johnson JA, Dallal GE. Dietary fat and serum lipids: an evaluation of the experimental data [published erratum appears in Am J Clin Nutr 1993 Aug;58(2):245]. Am J Clin Nutr. 1993;57:875-883.
43. Keys A. Effects of different dietary fats on plasma-lipid levels. Lancet. 1965;1:318-319.
44. Hegsted DM, McGandy RB, Myers ML, Stare FJ. Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr. 1965;17:281-295.
45. Yu S, Derr J, Etherton TD, Kris-Etherton PM. Plasma cholesterol-predictive equations demonstrate that stearic acid is neutral and monounsaturated fatty acids are hypocholesterolemic. Am J Clin Nutr. 1995;61:1129-1139.
46. Clarke R, Frost C, Collins R, Appleby P, Peto R. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ. 1997;314:112-117.
47. Chen CY, Blumberg JB. Phytochemical composition of nuts. Asia Pac J Clin Nutr. 2008;17(Suppl 1):329-332.
48. Racette SB, Spearie CA, Phillips KM, Lin X, Ma L, Ostlund RE Jr. Phytosterol-deficient and high-phytosterol diets developed for controlled feeding studies. J Am Diet Assoc. 2009;109:2043-2051.
49. Cohn JS, Kamili A, Wat E, Chung RW, Tandy S. Reduction in intestinal cholesterol absorption by various food components: mechanisms and implications. Atheroscler Suppl. 2010;11:45-48.
50. Racette SB, Lin X, Lefevre M, etal. Dose effects of dietary phytosterols on cholesterol metabolism: a controlled feeding study. Am J Clin Nutr. 2010;91:32-38.
51. Ostlund RE Jr, Racette SB, Okeke A, Stenson WF. Phytosterols that are naturally present in commercial corn oil significantly reduce cholesterol absorption in humans. Am J Clin Nutr. 2002;75:1000-1004.
52. Ikeda I, Tanabe Y, Sugano M. Effects of sitosterol and sitostanol on micellar solubility of cholesterol. J Nutr Sci Vitaminol (Tokyo). 1989;35:361-369.
53. Calpe-Berdiel L, Escolà-Gil JC, Blanco-Vaca F. New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism. Atherosclerosis. 2009;203:18-31.
54. Costet P. Molecular pathways and agents for lowering LDL-cholesterol in addition to statins. Pharmacol Ther. 2010;126:263-278.
55. Field FJ, Born E, Mathur SN. Effect of micellar beta-sitosterol on cholesterol metabolism in CaCo-2 cells. J Lipid Res. 1997;38:348-360.
56. Nguyen LB, Salen G, Shefer S, etal. Deficient ileal 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in sitosterolemia: sitosterol is not a feedback inhibitor of intestinal cholesterol biosynthesis. Metabolism. 1994;43:855-859.
57. Ho SS, Pal S. Margarine phytosterols decrease the secretion of atherogenic lipoproteins from HepG2 liver and Caco2 intestinal cells. Atherosclerosis. 2005;182:29-36.
58. Department of Health and Human Services and U.S. Department of Agriculture. Dietary Guidelines for Americans 2010. Accessed February 2011.
59. Pereira MA, O'Reilly E, Augustsson K, etal. Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med. 2004;164:370-376.
60. Streppel MT, Ocke MC, Boshuizen HC, Kok FJ, Kromhout D. Dietary fiber intake in relation to coronary heart disease and all-cause mortality over 40 years: the Zutphen Study. Am J Clin Nutr. 2008;88:1119-1125.
61. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999;69:30-42.
62. Salas-Salvadó J, Bulló M, Pérez-Heras A, Ros E. Dietary fibre, nuts and cardiovascular diseases. Br J Nutr. 2006;96(Suppl 2):S45-S51.
63. Schakel SF, Pettit J, Himes JH. Dietary fiber values for common foods. In: Spiller GA, ed. The CRC Handbook of Dietary Fiber in Human Nutrition, 3rd ed. London: CRC Press; 2001.
64. Marlett JA. Content and composition of dietary fiber in 117 frequently consumed foods. J Am Diet Assoc. 1992;92:175-186.
65. Shurpalekar KS, Doraiswamy TR, Sundaravalli OE, Rao MN. Effect of inclusion of cellulose in an "atherogenic" diet on the blood lipids of children. Nature. 1971;232:554-555.
66. Sundaravalli OE, Shurpalekar KS, Rao MN. Effects of dietary cellulose supplements on the body composition and cholesterol metabolism of albino rats. J Agric Food Chem. 1971;19:116-118.
67. Story JA, Kritchevsky D. Comparison of the binding of various bile acids and bile salts in vitro by several types of fiber. J Nutr. 1976;106:1292-1294.
68. Vahouny GV, Roy T, Gallo LL, Story JA, Kritchevsky D, Cassidy M. Dietary fibers. III. Effects of chronic intake on cholesterol absorption and metabolism in the rat. Am J Clin Nutr. 1980;33:2182-2191.
69. Cosgrove DJ. Expansive growth of plant cell walls. Plant Physiol Biochem. 2000;38:109-124.
70. Vahouny GV, Satchithanandam S, Chen I, etal. Dietary fiber and intestinal adaptation: effects on lipid absorption and lymphatic transport in the rat. Am J Clin Nutr. 1988;47:201-206.
71. Keys A, Grande F, Anderson JT. Fiber and pectin in the diet and serum cholesterol concentration in man. Proc Soc Exp Biol Med. 1961;106:555-558.
72. van Bennekum A, Nguyen D, Schulthess G, Hauser H, Phillips M. Mechanisms of cholesterol-lowering effects of dietary insoluble fibres: relationships with intestinal and hepatic cholesterol parameters. Br J Nutr. 2005;94:331-337.
73. Burton-Freeman B. Dietary fiber and energy regulation. J Nutr. 2000;130:272S-275S.
74. Hollis J, Mattes R. Effect of chronic consumption of almonds on body weight in healthy humans. Br J Nutr. 2007;98:651-656.
75. Fraser GE, Bennett HW, Jaceldo KB, Sabate J. Effect on body weight of a free 76 kilojoule (320 calorie) daily supplement of almonds for six months. J Am Coll Nutr. 2002;21:275-283.
76. Slavin JL. Dietary fiber: classification, chemical analyses, and food sources. J Am Diet Assoc. 1987;87:1164-1171.
77. Scheller HV, Ulvskov P. Hemicelluloses. Annu Rev Plant Biol. 2010;61:263-289.
78. Vanharanta M, Voutilainen S, Lakka TA, van der Lee M, Adlercreutz H, Salonen JT. Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study. Lancet. 1999;354:2112-2115.
79. Pan A, Yu D, Demark-Wahnefried W, Franco OH, Lin X. Meta-analysis of the effects of flaxseed interventions on blood lipids. Am J Clin Nutr. 2009;90:288-297.
80. Theuwissen E, Mensink RP. Water-soluble dietary fibers and cardiovascular disease. Physiol Behav. 2008;94:285-292.
81. Wolfe BM, Giovannetti PM. Short-term effects of substituting protein for carbohydrate in the diets of moderately hypercholesterolemic human subjects. Metabolism. 1991;40:338-343.
82. Appel LJ, Sacks FM, Carey VJ, etal. Effects of protein, unsaturated fat, and carbohydrate intakes on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA. 2005;294:2455-2464.
83. Kalopissis A-D, Griffaton G, Fau D. Inhibition of hepatic very-low-density lipoprotein secretion in obese Zucker rats adapted to a high-protein diet. Metabolism. 1995;44:19-29.
84. Gruffat D, Durand D, Graulet B, Bauchart D. Regulation of VLDL synthesis and secretion in the liver. Reprod Nutr Dev. 1996;36:375-389.
85. McGarry JD, Foster DW. Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem. 1980;49:395-420.
86. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature. 1990;343:425-430.
87. Balk E, Chung M, Chew P, etal. Effects of Soy on Health Outcomes. Rockville, MD: Agency for Healthcare Research and Quality; 2005.
88. Sugano M, Ishiwaki N, Nakashima K. Dietary protein-dependent modification of serum cholesterol level in rats. Significance of the arginine/lysine ratio. Ann Nutr Metab. 1984;28:192-199.
89. Sánchez A, Rubano DA, Shavlik GW, Hubbard R, Horning MC. Cholesterolemic effects of the lysine/arginine ratio in rabbits after initial early growth. Arch Latinoam Nutr. 1988;38:229-238.
90. Sánchez A, Rubano DA, Shavlik GW, Fagenstrom P, Register UD, Hubbard RW. Separate effects of dietary protein and fat on serum cholesterol levels: another view of amino acid content of proteins. Arch Latinoam Nutr. 1988;38:239-250.
91. Vahouny GV, Le T, Ifrim I, Satchithanandam S, Cassidy MM. Stimulation of intestinal cytokinetics and mucin turnover in rats fed wheat bran or cellulose. Am J Clin Nutr. 1985;41:895-900.
92. Kritchevsky D, Tepper SA, Czarnecki SK, Klurfeld DM. Atherogenicity of animal and vegetable protein: influence of the lysine to arginine ratio. Atherosclerosis. 1982;41:429-431.
93. Brufau G, Boatella J, Rafecas M. Nuts: source of energy and macronutrients. Br J Nutr. 2006;96(Suppl 2):S24-S28.
94. Kohls KJ, Kies C, Fox HM. Blood serum lipid levels of humans given arginine, lysine and tryptophan supplements without food. Nutr Rep Int. 1987;35:5-11.
95. Vega-López S, Matthan NR, Ausman LM, etal. Altering dietary lysine:arginine ratio has little effect on cardiovascular risk factors and vascular reactivity in moderately hypercholesterolemic adults. Atherosclerosis. 2010;210:555-562.
96. Kritchevsky D. Protein and atherosclerosis. J Nutr Sci Vitaminol (Tokyo). 1990;36(Suppl 2):S81-S86.
97. Huff MW, Carroll KK. Effects of dietary protein on turnover, oxidation, and absorption of cholesterol, and on steroid excretion in rabbits. J Lipid Res. 1980;21:546-548.
98. Sanchez A, Hubbard RW. Plasma amino acids and the insulin/glucagon ratio as an explanation for the dietary protein modulation of atherosclerosis. Med Hypotheses. 1991;35:324-329.
99. Yin W-H, Chen J-W, Tsai C, Chiang M-C, Young MS, Lin S-J. L-arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease. Clin Nutr. 2005;24:988-997.
100. Vanhoutte PM. Arginine and arginase: endothelial no synthase double crossed? Circ Res. 2008;102:866-868.
101. Durante W, Johnson FK, Johnson RA. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol. 2007;34:906-911.
102. Department of Health and Human Services and U.S. Department of Agriculture. Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans 2010. Accessed June 2010.
103. National Academy of Sciences, Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids 2000. Accessed June 2010.
104. Jambazian PR, Haddad E, Rajaram S, Tanzman J, Sabaté J. Almonds in the diet simultaneously improve plasma [alpha]-tocopherol concentrations and reduce plasma lipids. J Am Diet Assoc. 2005;105:449-454.
105. Traber MG, Atkinson J. Vitamin E, antioxidant and nothing more. Free Radic Biol Med. 2007;43:4-15.
106. Cordero Z, Drogan D, Weikert C, Boeing H. Vitamin E and risk of cardiovascular diseases: a review of epidemiologic and clinical trial studies. Crit Rev Food Sci Nutr. 2010;50:420-440.
107. Asplund K. Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review. J Intern Med. 2002;251:372-392.
108. Jenkins DJA, Kendall CWC, Marchie A, etal. Almonds reduce biomarkers of lipid peroxidation in older hyperlipidemic subjects. J Nutr. 2008;138:908-913.
109. Azzi A, Breyer I, Feher M, etal. Specific cellular responses to {alpha}-tocopherol. J Nutr. 2000;130:1649-1652.
110. Marino M, Distefano E, Pallottini V, Caporali S, Bruscalupi G, Trentalance A. Activation of IP(3)-protein kinase C-alpha signal transduction pathway precedes the changes of plasma cholesterol, hepatic lipid metabolism and induction of low-density lipoprotein receptor expression in 17-beta-oestradiol-treated rats. Exp Physiol. 2001;86:39-45.
111. Devaraj S, Hugou I, Jialal I. Alpha-tocopherol decreases CD36 expression in human monocyte-derived macrophages. J Lipid Res. 2001;42:521-527.
112. Valastyan S, Thakur V, Johnson A, Kumar K, Manor D. Novel transcriptional activities of vitamin E: inhibition of cholesterol biosynthesis. Biochemistry. 2007;47:744-752.
113. Landrier J-F, Gouranton E, Reboul E, etal. Vitamin E decreases endogenous cholesterol synthesis and apo-AI-mediated cholesterol secretion in Caco-2 cells. J Nutr Biochem. 2010;21:1207-1213.
114. National Academy of Sciences, Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride 1997. Accessed June 2010.
115. Champagne CM. Magnesium in hypertension, cardiovascular disease, metabolic syndrome, and other conditions: a review. Nutr Clin Prac. 2008;23:142-151.
116. Vaskonen T. Dietary minerals and modification of cardiovascular risk factors. J Nutr Biochem. 2003;14:492-506.
117. Djurhuus MS, Klitgaard NAH, Pedersen KK, etal. Magnesium reduces insulin-stimulated glucose uptake and serum lipid concentrations in type 1 diabetes. Metabolism. 2001;50:1409-1417.
118. Rasmussen HS, Aurup P, Goldstein K, etal. Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease: a double-blind, placebo-controlled study. Arch Intern Med. 1989;149:1050-1053.
119. Houtman JP. Trace elements and cardiovascular diseases. J Cardiovasc Risk. 1996;3:18-25.
120. Tiber AM, Sakhaii M, David Joffe C, Ratnaparkhi MV. Relative value of plasma copper, zinc, lipids and lipoproteins as markers for coronary artery disease. Atherosclerosis. 1986;62:105-110.
121. Jones AA, DiSilvestro RA, Coleman M, Wagner TL. Copper supplementation of adult men: effects on blood copper enzyme activities and indicators of cardiovascular disease risk. Metabolism. 1997;46:1380-1383.
122. Appel LJ, Moore TJ, Obarzanek E, etal. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336:1117-1124.
123. Ellis PR, Kendall CWC, Ren Y, etal. Role of cell walls in the bioaccessibility of lipids in almond seeds. Am J Clin Nutr. 2004;80:604-613.
124. Mandalari G, Faulks RM, Rich GT, etal. Release of protein, lipid, and vitamin E from almond seeds during digestion. J Agric Food Chem. 2008;56:3409-3416.
125. Berry SEE, Tydeman EA, Lewis HB, etal. Manipulation of lipid bioaccessibility of almond seeds influences postprandial lipemia in healthy human subjects. Am J Clin Nutr. 2008;88:922-929.
126. Li N, Jia X, Chen CYO, etal. Almond consumption reduces oxidative DNA damage and lipid peroxidation in male smokers. J Nutr. 2007;137:2717-2722.
127. Chen C-Y, Milbury PE, Chung S-K, Blumberg J. Effect of almond skin polyphenolics and quercetin on human LDL and apolipoprotein B-100 oxidation and conformation. J Nutr Biochem. 2007;18:785-794.
128. Chen C-Y, Milbury PE, Lapsley K, Blumberg JB. Flavonoids from almond skins are bioavailable and act synergistically with vitamins C and E to enhance hamster and human LDL resistance to oxidation. J Nutr. 2005;135:1366-1373.
129. Jenkins DJA, Kendall CWC, Marchie A, etal. Effects of a dietary portfolio of cholesterol-lowering foods versus lovastatin on serum lipids and C-reactive protein. JAMA. 2003;290:502-510.
130. Jenkins DJA, Kendall CWC, Marchie A, etal. Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Am J Clin Nutr. 2005;81:380-387.